Search Results

You searched for all publications:

with publication states 'Published (Approved)'
published in journal 'Acs Chemical Biology'

Search Again...

These results only include publications that have been reviewed and processed by Diamond Light Source. To also view papers that have not yet been processed click here.

You can use the folder icon under Actions to collate papers as required. You can then click on View Folder in the left-hand navigation to review and/or download your folder.

Exact matches
Related results

63 items found (0 items not approved), displaying 1 to 10.[First/Prev] 1, 2, 3, 4, 5, 6, 7 [Next/Last]

Instruments / Technical Area	Publication Details	Published
I03-Macromolecular Crystallography I24-Microfocus Macromolecular Crystallography	3-Oxo-β-sultam as a sulfonylating chemotype for inhibition of serine hydrolases and activity-based protein profiling Luís A. R. Carvalho , Vanessa T. Almeida , Jose A. Brito , Kenneth M. Lum , Tânia F. Oliveira , Rita C. Guedes , Lídia M. Gonçalves , Susana D. Lucas , Benjamin F. Cravatt , Margarida Archer , Rui Moreira Acs Chemical Biology DOI: 10.1021/acschembio.0c00090 Diamond Proposal Number(s): [20161] Show Abstract ▼ Abstract: 3-Oxo-β-sultams are four-membered ring ambident electrophiles that can react with nucleophiles either at the carbonyl carbon or at the sulfonyl sulfur atoms, and that have been reported to inhibit serine hydrolases via acylation of the active-site serine residue. We have developed a panel of 3-oxo-β-sultam inhibitors and show, through crystallographic data, that they are regioselective sulfonylating electrophiles, covalently binding to the catalytic serine of human and porcine elastases through the sulfur atom. Application of 3-oxo-β-sultam-derived activity-based probes in a human proteome revealed their potential to label disease-related serine hydrolases and proteasome subunits. Activity-based protein profiling applications of 3-oxo-β-sultams should open up new opportunities to investigate these classes of enzymes in complex proteomes and expand the toolbox of available sulfur-based covalent protein modifiers in chemical biology.	Mar 2020
I04-Macromolecular Crystallography	A PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3 Anders E. G. Lindgren , Tobias Karlberg , Ann-Gerd Thorsell , Mareike Hesse , Sara Spjut , Torun Ekblad , C. David Andersson , Ana Filipa Pinto , Johan Weigelt , Michael O. Hottiger , Anna Linusson , Mikael Elofsson , Herwig Schüler Acs Chemical Biology 8 (8) DOI: 10.1021/cb4002014 PMID: 23742272 Diamond Proposal Number(s): [6603] Show Abstract ▼ Abstract: Inhibiting ADP-ribosyl transferases with PARP-inhibitors is considered a promising strategy for the treatment of many cancers and ischemia, but most of the cellular targets are poorly characterized. Here, we describe an inhibitor of ADP-ribosyltransferase-3/poly(ADP-ribose) polymerase-3 (ARTD3), a regulator of DNA repair and mitotic progression. In vitro profiling against 12 members of the enzyme family suggests selectivity for ARTD3, and crystal structures illustrate the molecular basis for inhibitor selectivity. The compound is active in cells, where it elicits ARTD3-specific effects at submicromolar concentration. Our results show that by targeting the nicotinamide binding site, selective inhibition can be achieved among the closest relatives of the validated clinical target, ADP-ribosyltransferase-1/poly(ADP-ribose) polymerase-1.	Jun 2013
I04-Macromolecular Crystallography	A TPX2 proteomimetic has enhanced affinity for aurora-a due to hydrocarbon stapling of a helix Yana K. Rennie , Patrick Mcintyre , Tito Akindele , Richard Bayliss , Andrew G. Jamieson Acs Chemical Biology 11, 3383 - 3390 DOI: 10.1021/acschembio.6b00727 Diamond Proposal Number(s): [10369] Open Access Show Abstract ▼ Abstract: Inhibition of protein kinases using ATP-competitive compounds is an important strategy in drug discovery. In contrast, the allosteric regulation of kinases through the disruption of protein–protein interactions has not been widely adopted, despite the potential for selective targeting. Aurora-A kinase regulates mitotic entry and mitotic spindle assembly and is a promising target for anticancer therapy. The microtubule-associated protein TPX2 activates Aurora-A through binding to two sites. Aurora-A recognition is mediated by two motifs within the first 43 residues of TPX2, connected by a flexible linker. To characterize the contributions of these three structural elements, we prepared a series of TPX2 proteomimetics and investigated their binding affinity for Aurora-A using isothermal titration calorimetry. A novel stapled TPX2 peptide was developed that has improved binding affinity for Aurora-A and mimics the function of TPX2 in activating Aurora-A’s autophosphorylation. We conclude that the helical region of TPX2 folds upon binding Aurora-A, and that stabilization of this helix does not compromise Aurora-A activation. This study demonstrates that the preparation of these proteomimetics using modern synthesis methods is feasible and their biochemical evaluation demonstrates the power of proteomimetics as tool compounds for investigating PPIs involving intrinsically disordered regions of proteins.	Dec 2016
I02-Macromolecular Crystallography I04-Macromolecular Crystallography	A chemical-genetic approach to generate selective covalent inhibitors of protein kinases Alvin Kung , Marianne Schimpl , Arunika Ishani Ekanayake , Ying-Chu Chen , Ross Overman , Chao Zhang Acs Chemical Biology DOI: 10.1021/acschembio.6b01083 Show Abstract ▼ Abstract: Although a previously developed bump-hole approach has proven powerful in generating specific inhibitors for mapping functions of protein kinases, its application is limited by the intolerance of the large-to-small mutation by certain kinases and the inability to control two kinases separately in the same cells. Herein, we describe the development of an alternative chemical-genetic approach to overcome these limitations. Our approach features the use of an engineered cysteine residue at a particular position as a reactive feature to sensitize a kinase of interest to selective covalent blockade by electrophilic inhibitors and is thus termed Ele-Cys approach. We successfully applied the Ele-Cys approach to identify selective covalent inhibitors of a receptor tyrosine kinase EphB1, and solved cocrystal structures to determine the mode of covalent binding. Importantly, the Ele-Cys and bump-hole approaches afforded orthogonal inhibition of two distinct kinases in the cell, opening the door to their combined use in the study of multi-kinase signaling pathways.	May 2017
I24-Microfocus Macromolecular Crystallography	A key role for the periplasmic PfeE esterase in iron acquisition via the siderophore Enterobactin in Pseudomonas aeruginosa Quentin Perraud , Lucile Moynie , Véronique Gasser , Mathilde Munier , Julien Godet , Françoise Hoegy , Yves Mély , Gaëtan L. A. Mislin , James H. Naismith , Isabelle J. Schalk Acs Chemical Biology DOI: 10.1021/acschembio.8b00543 Show Abstract ▼ Abstract: Enterobactin (ENT) is a siderophore (iron-chelating compound) produced by Escherichia coli in order to gain access to iron, an essential nutriment for bacterial growth. ENT is used as an exosiderophore by the opportunistic human pathogen Pseudomonas aeruginosa with transport of ferri-ENT across the bacterial outer membrane by the transporter PfeA. Next to pfeA gene on the chromosome is localized a gene encoding for an esterase, PfeE, whose transcription is regulated, as for pfeA, by the presence of ENT in bacterial environment. Purified PfeE hydrolyzed ferri-ENT into three molecules of 2,3 DHBS (2,3 dihydroxybenzoylserine) still complexed with ferric iron, and complete dissociation of iron from ENT chelating groups was only possible in the presence of both PfeE and an iron reducer, such as DTT. The crystal structure of PfeE and an inactive PfeE mutant complexed with ferri-ENT or a non-hydrolysable ferri-catechol complex allowed identification of the enzyme binding site and the catalytic triad. Finally, cell fractionation and fluorescence microscopy showed periplasmic localization of PfeE in P. aeruginosa cells. Thus, the molecular mechanism of iron release from ENT in P. aeruginosa differs from that previously described in E. coli. In P. aeruginosa, siderophore hydrolysis occurs in the periplasm, with ENT never reaching the bacterial cytoplasm. In E. coli, ferri-ENT crosses the inner membrane via the ABC transporter FepBCD and ferri-ENT is hydrolyzed by the esterase Fes only once it is in the cytoplasm.	Aug 2018
I24-Microfocus Macromolecular Crystallography	A novel allosteric inhibitor of the uridine diphosphate n-acetylglucosamine pyrophosphorylase from Trypanosoma brucei Michael D. Urbaniak , Iain T. Collie , Wenxia Fang , Tonia Aristotelous , Susanne Eskilsson , Olawale G. Raimi , Justin Harrison , Iva Hopkins Navratilova , Julie A. Frearson , Daan M. F. Van Aalten , Michael A. J. Ferguson Acs Chemical Biology 8 (9), 1981 - 1987 DOI: 10.1021/cb400411x PMID: 23834437 Open Access Show Abstract ▼ Abstract: Bacteriocin; P aeruginosa.; pyocin S2; pyocin AP41; immunity protein Uridine diphosphate N-acetylglucosamine pyrophosphorylase (UAP) catalyzes the final reaction in the biosynthesis of UDP-GlcNAc, an essential metabolite in many organisms including Trypanosoma brucei, the etiological agent of Human African Trypanosomiasis. High-throughput screening of recombinant T. brucei UAP identified a UTP-competitive inhibitor with selectivity over the human counterpart despite the high level of conservation of active site residues. Biophysical characterization of the UAP enzyme kinetics revealed that the human and trypanosome enzymes both display a strictly ordered bi−bi mechanism, but with the order of substrate binding reversed. Structural characterization of the T. brucei UAP−inhibitor complex revealed that the inhibitor binds at an allosteric site absent in the human homologue that prevents the conformational rearrangement required to bind UTP. The identification of a selective inhibitory allosteric binding site in the parasite enzyme has therapeutic potential.	Sep 2013
I02-Macromolecular Crystallography I03-Macromolecular Crystallography	Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase Mathieu Métifiot , Kasthuraiah Maddali , Barry C. Johnson , Stephen Hare , Steven J. Smith , Xue Zhi Zhao , Christophe Marchand , Terrence R. Burke , Stephen H. Hughes , Peter Cherepanov , Yves Pommier Acs Chemical Biology 8 (1) DOI: 10.1021/cb300471n PMID: 23075516 Show Abstract ▼ Abstract: On the basis of a series of lactam and phthalimide derivatives that inhibit HIV-1 integrase, we developed a new molecule, XZ-259, with biochemical and antiviral activities comparable to raltegravir. We determined the crystal structures of XZ-259 and four other derivatives in complex with the prototype foamy virus intasome. The compounds bind at the integrase-Mg2+-DNA interface of the integrase active site. In biochemical and antiviral assays, XZ-259 inhibits raltegravir-resistant HIV-1 integrases harboring the Y143R mutation. Molecular modeling is also presented suggesting that XZ-259 can bind in the HIV-1 intasome with its dimethyl sulfonamide group adopting two opposite orientations. Molecular dynamics analyses of the HIV-1 intasome highlight the importance of the viral DNA in drug potency	Dec 2012
I03-Macromolecular Crystallography I04-1-Macromolecular Crystallography (fixed wavelength)	Allosteric competitive inhibitors of the glucose-1-phosphate thymidylyltransferase (RmlA) from Pseudomonas aeruginosa Magnus Alphey , Lisa Pirrie , Leah S. Torrie , Wassila Abdelli Boulkeroua , Mary Gardiner , Aurijit Sarkar , Marko Maringer , Wulf Oehlmann , Ruth Brenk , Michael S. Scherman , Michael Mcneil , Martin Rejzek , Robert A. Field , Mahavir Singh , David Gray , Nicholas J. Westwood , James H. Naismith Acs Chemical Biology 8 (2) DOI: 10.1021/cb300426u PMID: 23138692 Open Access Show Abstract ▼ Abstract: Glucose-1-phosphate thymidylyltransferase (RmlA) catalyzes the condensation of glucose-1-phosphate (G1P) with deoxy-thymidine triphosphate (dTTP) to yield dTDP-d-glucose and pyrophosphate. This is the first step in the l-rhamnose biosynthetic pathway. l-Rhamnose is an important component of the cell wall of many microorganisms, including Mycobacterium tuberculosis and Pseudomonas aeruginosa. Here we describe the first nanomolar inhibitors of P. aeruginosa RmlA. These thymine analogues were identified by high-throughput screening and subsequently optimized by a combination of protein crystallography, in silico screening, and synthetic chemistry. Some of the inhibitors show inhibitory activity against M. tuberculosis. The inhibitors do not bind at the active site of RmlA but bind at a second site remote from the active site. Despite this, the compounds act as competitive inhibitors of G1P but with high cooperativity. This novel behavior was probed by structural analysis, which suggests that the inhibitors work by preventing RmlA from undergoing the conformational change key to its ordered bi-bi mechanism.	Nov 2012
I02-Macromolecular Crystallography I04-Macromolecular Crystallography	BTN3A1 discriminates γδ T cell phosphoantigens from non-antigenic small molecules via a conformational sensor in its B30.2 domain Mahboob Salim , Timothy J. Knowles , Alfie T. Baker , Martin S. Davey , Mark Jeeves , Pooja Sridhar , John Wilkie , Carrie R. Willcox , Hachemi Kadri , Taher E. Taher , Pierre Vantourout , Adrian Hayday , Youcef Mehellou , Fiyaz Mohammed , Benjamin E. Willcox Acs Chemical Biology DOI: 10.1021/acschembio.7b00694 Diamond Proposal Number(s): [14692] Show Abstract ▼ Abstract: Human Vγ9/Vδ2 T-cells detect tumour cells and microbial infections by recognising small phosphorylated prenyl metabolites termed phosphoantigens (P-Ag). The type-1 transmembrane protein Butyrophilin 3A1 (BTN3A1) is critical to the P-Ag-mediated activation of Vγ9/Vδ2 T-cells, however, the molecular mechanisms involved in BTN3A1-mediated metabolite sensing are unclear, including how P-Ag are discriminated from non-antigenic small molecules. Here, we utilised NMR and X-ray crystallography to probe P-Ag sensing by BTN3A1. Whereas the BTN3A1 Immunoglobulin Variable domain failed to bind P-Ag, the intracellular B30.2 domain bound a range of negatively-charged small molecules, including P-Ag, in a positively-charged surface pocket. However, NMR chemical shift perturbations indicated BTN3A1 discriminated P-Ag from non-antigenic small molecules by their ability to induce a specific conformational change in the B30.2 domain that propagated from the P-Ag binding site to distal parts of the domain. These results suggest BTN3A1 selectively detects P-Ag intracellularly via a conformational antigenic sensor in its B30.2 domain, and have implications for rational design of antigens for Vγ9/Vδ2 -based T-cell immunotherapies.	Sep 2017
I24-Microfocus Macromolecular Crystallography	Bacterial β-glucosidase reveals the structural and functional basis of genetic defects in human glucocerebrosidase 2 (GBA2) Ratana Charoenwattanasatien , Salila Pengthaisong , Imogen Breen , Risa Mutoh , Sompong Sansenya , Yanling Hua , Anupong Tankrathok , Liang Wu , Chomphunuch Songsiriritthigul , Hideaki Tanaka , Spencer J. Williams , Gideon Davies , Genji Kurisu , James R. Ketudat Cairns Acs Chemical Biology DOI: 10.1021/acschembio.6b00192 Open Access Show Abstract ▼ Abstract: Human glucosylcerebrosidase 2 (GBA2) of the CAZy family GH116 is responsible for the breakdown of glycosphingolipids on the cytoplasmic face of the endoplasmic reticulum and Golgi apparatus. Genetic defects in GBA2 result in spastic paraplegia and cerebellar ataxia, while cross-talk between GBA2 and GBA1 glucosylceramidases may affect Gaucher disease. Here, we report the first three-dimensional structure for any GH116 enzyme, Thermoanaerobacterium xylanolyticum TxGH116 β-glucosidase, alone and in complex with diverse ligands. These structures allow identification of the glucoside binding and active site residues, which are shown to be conserved with GBA2. Mutagenic analysis of TxGH116 and structural modeling of GBA2 provide a detailed structural and functional rationale for pathogenic missense mutations of GBA2.	May 2016

Publications Database

Search Results

You searched for all publications:

Search Again...

Subject Areas (check all that apply) select all

Instruments used to collect data (check all that apply) select all

Collaborations involved (check all that apply) select all

Diamond Offline Facilities used

Relevant Technical Areas (check all that apply) select all

Menu for Anonymous User